GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Arntl
|
ENSMUSG00000055116.7 | aryl hydrocarbon receptor nuclear translocator-like |
Tfe3
|
ENSMUSG00000000134.11 | transcription factor E3 |
Mlx
|
ENSMUSG00000017801.9 | MAX-like protein X |
Mitf
|
ENSMUSG00000035158.9 | melanogenesis associated transcription factor |
Mlxipl
|
ENSMUSG00000005373.7 | MLX interacting protein-like |
Tfec
|
ENSMUSG00000029553.7 | transcription factor EC |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Tfec | mm10_v2_chr6_-_16898441_16898459 | -0.84 | 2.2e-10 | Click! |
Mlxipl | mm10_v2_chr5_+_135106881_135106918 | 0.75 | 1.5e-07 | Click! |
Arntl | mm10_v2_chr7_+_113207465_113207595 | 0.46 | 4.4e-03 | Click! |
Mlx | mm10_v2_chr11_+_101087277_101087323 | 0.45 | 5.3e-03 | Click! |
Tfe3 | mm10_v2_chrX_+_7762652_7762695 | -0.43 | 9.1e-03 | Click! |
Mitf | mm10_v2_chr6_+_97807014_97807067 | 0.26 | 1.2e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr8_+_13159135 | 25.04 |
ENSMUST00000033824.6
|
Lamp1
|
lysosomal-associated membrane protein 1 |
chr1_+_130826676 | 20.46 |
ENSMUST00000027675.7
|
Pigr
|
polymeric immunoglobulin receptor |
chr1_+_130826762 | 18.79 |
ENSMUST00000133792.1
|
Pigr
|
polymeric immunoglobulin receptor |
chr7_-_97417730 | 16.69 |
ENSMUST00000043077.7
|
Thrsp
|
thyroid hormone responsive |
chr10_+_127063527 | 13.55 |
ENSMUST00000006911.5
|
Cdk4
|
cyclin-dependent kinase 4 |
chr3_+_90052814 | 13.18 |
ENSMUST00000160640.1
ENSMUST00000029552.6 ENSMUST00000162114.1 ENSMUST00000068798.6 |
4933434E20Rik
|
RIKEN cDNA 4933434E20 gene |
chr9_-_50561261 | 12.92 |
ENSMUST00000034568.5
|
Tex12
|
testis expressed gene 12 |
chr17_-_26939464 | 12.16 |
ENSMUST00000025027.8
ENSMUST00000114935.1 |
Cuta
|
cutA divalent cation tolerance homolog (E. coli) |
chr11_-_116199040 | 11.76 |
ENSMUST00000066587.5
|
Acox1
|
acyl-Coenzyme A oxidase 1, palmitoyl |
chr1_+_166254095 | 11.20 |
ENSMUST00000111416.1
|
Ildr2
|
immunoglobulin-like domain containing receptor 2 |
chr3_+_67582737 | 9.90 |
ENSMUST00000029344.8
|
Mfsd1
|
major facilitator superfamily domain containing 1 |
chr12_-_84450944 | 9.69 |
ENSMUST00000085192.5
|
Aldh6a1
|
aldehyde dehydrogenase family 6, subfamily A1 |
chr2_-_25356319 | 9.23 |
ENSMUST00000028332.7
|
Dpp7
|
dipeptidylpeptidase 7 |
chr11_-_116198701 | 9.10 |
ENSMUST00000072948.4
|
Acox1
|
acyl-Coenzyme A oxidase 1, palmitoyl |
chr9_-_22002599 | 9.08 |
ENSMUST00000115336.2
ENSMUST00000044926.5 |
Ccdc151
|
coiled-coil domain containing 151 |
chr10_-_128923948 | 8.88 |
ENSMUST00000131271.1
|
Bloc1s1
|
biogenesis of lysosome-related organelles complex-1, subunit 1 |
chr15_-_3995708 | 8.60 |
ENSMUST00000046633.8
|
AW549877
|
expressed sequence AW549877 |
chr4_-_148038769 | 8.58 |
ENSMUST00000030879.5
ENSMUST00000137724.1 |
Clcn6
|
chloride channel 6 |
chr10_+_41519493 | 8.53 |
ENSMUST00000019962.8
|
Cd164
|
CD164 antigen |
chr2_+_102706356 | 8.45 |
ENSMUST00000123759.1
ENSMUST00000111212.1 ENSMUST00000005220.4 |
Slc1a2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
chr10_-_128922888 | 8.41 |
ENSMUST00000135161.1
|
Rdh5
|
retinol dehydrogenase 5 |
chr10_-_128923439 | 8.16 |
ENSMUST00000153731.1
ENSMUST00000026405.3 |
Bloc1s1
|
biogenesis of lysosome-related organelles complex-1, subunit 1 |
chr7_+_27195781 | 7.92 |
ENSMUST00000108379.1
ENSMUST00000179391.1 |
BC024978
|
cDNA sequence BC024978 |
chr15_+_10215955 | 7.76 |
ENSMUST00000130720.1
|
Prlr
|
prolactin receptor |
chr2_-_130424242 | 7.71 |
ENSMUST00000089581.4
|
Pced1a
|
PC-esterase domain containing 1A |
chr7_-_46742979 | 7.70 |
ENSMUST00000128088.1
|
Saa1
|
serum amyloid A 1 |
chr17_-_34743849 | 7.52 |
ENSMUST00000069507.8
|
C4b
|
complement component 4B (Chido blood group) |
chr2_+_122234749 | 7.40 |
ENSMUST00000110551.3
|
Sord
|
sorbitol dehydrogenase |
chr9_-_57683644 | 7.36 |
ENSMUST00000034860.3
|
Cyp1a2
|
cytochrome P450, family 1, subfamily a, polypeptide 2 |
chr9_+_55326913 | 7.28 |
ENSMUST00000085754.3
ENSMUST00000034862.4 |
AI118078
|
expressed sequence AI118078 |
chr8_+_3500451 | 6.98 |
ENSMUST00000004683.6
ENSMUST00000160338.1 |
Mcoln1
|
mucolipin 1 |
chr4_+_129335593 | 6.97 |
ENSMUST00000141235.1
|
Zbtb8os
|
zinc finger and BTB domain containing 8 opposite strand |
chr8_-_84846860 | 6.86 |
ENSMUST00000003912.6
|
Calr
|
calreticulin |
chr9_+_46012810 | 6.86 |
ENSMUST00000126865.1
|
Sik3
|
SIK family kinase 3 |
chr10_+_121365078 | 6.84 |
ENSMUST00000040344.6
|
Gns
|
glucosamine (N-acetyl)-6-sulfatase |
chr16_+_45158725 | 6.59 |
ENSMUST00000023343.3
|
Atg3
|
autophagy related 3 |
chr4_-_117887292 | 6.58 |
ENSMUST00000150204.1
ENSMUST00000147845.1 ENSMUST00000036380.7 ENSMUST00000136596.1 |
Atp6v0b
|
ATPase, H+ transporting, lysosomal V0 subunit B |
chr5_+_30921825 | 6.54 |
ENSMUST00000117435.1
|
Khk
|
ketohexokinase |
chr16_-_5203981 | 6.51 |
ENSMUST00000147567.1
ENSMUST00000023911.4 |
Nagpa
|
N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase |
chr4_+_129336012 | 6.47 |
ENSMUST00000119480.1
|
Zbtb8os
|
zinc finger and BTB domain containing 8 opposite strand |
chr10_-_4432312 | 6.38 |
ENSMUST00000126102.1
ENSMUST00000131853.1 ENSMUST00000042251.4 |
Rmnd1
|
required for meiotic nuclear division 1 homolog (S. cerevisiae) |
chr4_-_117887279 | 6.33 |
ENSMUST00000132073.1
|
Atp6v0b
|
ATPase, H+ transporting, lysosomal V0 subunit B |
chr17_-_56609689 | 6.23 |
ENSMUST00000052832.5
|
2410015M20Rik
|
RIKEN cDNA 2410015M20 gene |
chr11_-_113710017 | 6.21 |
ENSMUST00000018871.1
|
Cpsf4l
|
cleavage and polyadenylation specific factor 4-like |
chr2_+_164833781 | 6.21 |
ENSMUST00000143780.1
|
Ctsa
|
cathepsin A |
chr17_+_24850484 | 6.16 |
ENSMUST00000118788.1
|
Hagh
|
hydroxyacyl glutathione hydrolase |
chr11_+_98348404 | 6.07 |
ENSMUST00000078694.6
|
Ppp1r1b
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B |
chr10_-_39960144 | 6.05 |
ENSMUST00000095749.4
|
G630090E17Rik
|
RIKEN cDNA G630090E17 gene |
chr7_+_46796088 | 6.02 |
ENSMUST00000006774.4
ENSMUST00000165031.1 |
Gtf2h1
|
general transcription factor II H, polypeptide 1 |
chr7_-_126583177 | 5.98 |
ENSMUST00000098036.2
ENSMUST00000032962.4 |
Cln3
|
ceroid lipofuscinosis, neuronal 3, juvenile (Batten, Spielmeyer-Vogt disease) |
chr7_+_101905837 | 5.89 |
ENSMUST00000033131.6
|
Lamtor1
|
late endosomal/lysosomal adaptor, MAPK and MTOR activator 1 |
chr8_-_106136792 | 5.88 |
ENSMUST00000146940.1
|
Esrp2
|
epithelial splicing regulatory protein 2 |
chrX_+_103356464 | 5.82 |
ENSMUST00000116547.2
|
Chic1
|
cysteine-rich hydrophobic domain 1 |
chr3_-_89773221 | 5.81 |
ENSMUST00000038450.1
|
4632404H12Rik
|
RIKEN cDNA 4632404H12 gene |
chr2_+_164833841 | 5.79 |
ENSMUST00000152721.1
|
Ctsa
|
cathepsin A |
chr5_-_34187670 | 5.75 |
ENSMUST00000042701.6
ENSMUST00000119171.1 |
Mxd4
|
Max dimerization protein 4 |
chr7_-_99695572 | 5.75 |
ENSMUST00000137914.1
|
Slco2b1
|
solute carrier organic anion transporter family, member 2b1 |
chr8_-_106136890 | 5.69 |
ENSMUST00000115979.2
|
Esrp2
|
epithelial splicing regulatory protein 2 |
chr9_+_74953053 | 5.64 |
ENSMUST00000170846.1
|
Fam214a
|
family with sequence similarity 214, member A |
chr8_-_111630325 | 5.61 |
ENSMUST00000070004.3
|
Ldhd
|
lactate dehydrogenase D |
chr10_-_4432285 | 5.57 |
ENSMUST00000155172.1
|
Rmnd1
|
required for meiotic nuclear division 1 homolog (S. cerevisiae) |
chr3_+_130617448 | 5.54 |
ENSMUST00000166187.1
ENSMUST00000072271.6 |
Etnppl
|
ethanolamine phosphate phospholyase |
chr4_+_104766334 | 5.45 |
ENSMUST00000065072.6
|
C8b
|
complement component 8, beta polypeptide |
chr2_-_30286312 | 5.39 |
ENSMUST00000100219.3
|
Dolk
|
dolichol kinase |
chr1_+_75142775 | 5.38 |
ENSMUST00000097694.4
|
Fam134a
|
family with sequence similarity 134, member A |
chr16_-_45158650 | 5.37 |
ENSMUST00000023344.3
|
Slc35a5
|
solute carrier family 35, member A5 |
chr1_+_74713551 | 5.28 |
ENSMUST00000027356.5
|
Cyp27a1
|
cytochrome P450, family 27, subfamily a, polypeptide 1 |
chr2_-_130424673 | 5.25 |
ENSMUST00000110277.1
|
Pced1a
|
PC-esterase domain containing 1A |
chr9_-_87255536 | 5.19 |
ENSMUST00000093802.4
|
4922501C03Rik
|
RIKEN cDNA 4922501C03 gene |
chr15_+_102921103 | 5.16 |
ENSMUST00000001700.6
|
Hoxc13
|
homeobox C13 |
chr7_-_46795881 | 5.07 |
ENSMUST00000107653.1
ENSMUST00000107654.1 ENSMUST00000014562.7 ENSMUST00000152759.1 |
Hps5
|
Hermansky-Pudlak syndrome 5 homolog (human) |
chr11_+_69991061 | 5.06 |
ENSMUST00000018711.8
|
Gabarap
|
gamma-aminobutyric acid receptor associated protein |
chr14_+_69171576 | 5.05 |
ENSMUST00000062437.8
|
Nkx2-6
|
NK2 homeobox 6 |
chr2_+_121449362 | 5.03 |
ENSMUST00000110615.1
ENSMUST00000099475.5 |
Serf2
|
small EDRK-rich factor 2 |
chr1_+_5083105 | 5.03 |
ENSMUST00000044369.7
|
Atp6v1h
|
ATPase, H+ transporting, lysosomal V1 subunit H |
chr7_-_99695628 | 4.94 |
ENSMUST00000145381.1
|
Slco2b1
|
solute carrier organic anion transporter family, member 2b1 |
chr10_-_95416850 | 4.92 |
ENSMUST00000020215.9
|
Socs2
|
suppressor of cytokine signaling 2 |
chr17_+_45563928 | 4.92 |
ENSMUST00000041353.6
|
Slc35b2
|
solute carrier family 35, member B2 |
chr4_-_129239165 | 4.86 |
ENSMUST00000097873.3
|
C77080
|
expressed sequence C77080 |
chr9_+_46012822 | 4.82 |
ENSMUST00000120463.2
ENSMUST00000120247.1 |
Sik3
|
SIK family kinase 3 |
chr5_+_24428208 | 4.80 |
ENSMUST00000115049.2
|
Slc4a2
|
solute carrier family 4 (anion exchanger), member 2 |
chr16_+_20672716 | 4.77 |
ENSMUST00000044783.7
ENSMUST00000115463.1 ENSMUST00000142344.1 ENSMUST00000073840.5 ENSMUST00000140576.1 ENSMUST00000115457.1 |
Eif4g1
|
eukaryotic translation initiation factor 4, gamma 1 |
chr15_+_10714836 | 4.74 |
ENSMUST00000180604.1
|
4930556M19Rik
|
RIKEN cDNA 4930556M19 gene |
chr13_-_92131494 | 4.73 |
ENSMUST00000099326.3
ENSMUST00000146492.1 |
Rasgrf2
|
RAS protein-specific guanine nucleotide-releasing factor 2 |
chr11_+_120673018 | 4.64 |
ENSMUST00000106158.2
ENSMUST00000103016.1 ENSMUST00000168714.1 |
Aspscr1
|
alveolar soft part sarcoma chromosome region, candidate 1 (human) |
chr6_-_72235559 | 4.64 |
ENSMUST00000042646.7
|
Atoh8
|
atonal homolog 8 (Drosophila) |
chr5_-_139814025 | 4.63 |
ENSMUST00000146780.1
|
Tmem184a
|
transmembrane protein 184a |
chr10_-_62486772 | 4.58 |
ENSMUST00000105447.3
|
Vps26a
|
vacuolar protein sorting 26 homolog A (yeast) |
chr7_-_99695809 | 4.52 |
ENSMUST00000107086.2
|
Slco2b1
|
solute carrier organic anion transporter family, member 2b1 |
chr6_-_85869128 | 4.50 |
ENSMUST00000045008.7
|
Cml2
|
camello-like 2 |
chr3_+_130617645 | 4.48 |
ENSMUST00000163620.1
|
Etnppl
|
ethanolamine phosphate phospholyase |
chr11_-_60352869 | 4.47 |
ENSMUST00000095254.5
ENSMUST00000102683.4 ENSMUST00000093048.6 ENSMUST00000093046.6 ENSMUST00000064019.8 ENSMUST00000102682.4 |
Tom1l2
|
target of myb1-like 2 (chicken) |
chr4_+_104766308 | 4.45 |
ENSMUST00000031663.3
|
C8b
|
complement component 8, beta polypeptide |
chr8_+_104591464 | 4.45 |
ENSMUST00000059588.6
|
Pdp2
|
pyruvate dehyrogenase phosphatase catalytic subunit 2 |
chr10_-_62486575 | 4.45 |
ENSMUST00000092473.3
|
Vps26a
|
vacuolar protein sorting 26 homolog A (yeast) |
chr7_-_126377401 | 4.43 |
ENSMUST00000119846.1
ENSMUST00000119754.1 ENSMUST00000032994.8 |
Spns1
|
spinster homolog 1 |
chr8_-_93229517 | 4.42 |
ENSMUST00000176282.1
ENSMUST00000034173.7 |
Ces1e
|
carboxylesterase 1E |
chr10_-_95417099 | 4.42 |
ENSMUST00000135822.1
|
Socs2
|
suppressor of cytokine signaling 2 |
chr11_+_120672992 | 4.41 |
ENSMUST00000026135.8
|
Aspscr1
|
alveolar soft part sarcoma chromosome region, candidate 1 (human) |
chr16_+_5233615 | 4.36 |
ENSMUST00000100196.2
ENSMUST00000049207.8 |
Alg1
|
asparagine-linked glycosylation 1 (beta-1,4-mannosyltransferase) |
chr7_+_46751832 | 4.35 |
ENSMUST00000075982.2
|
Saa2
|
serum amyloid A 2 |
chr11_-_98775333 | 4.34 |
ENSMUST00000064941.6
|
Nr1d1
|
nuclear receptor subfamily 1, group D, member 1 |
chr6_-_85707858 | 4.29 |
ENSMUST00000179613.1
|
Gm4477
|
predicted gene 4477 |
chr17_+_24850515 | 4.29 |
ENSMUST00000154363.1
ENSMUST00000169200.1 |
Hagh
|
hydroxyacyl glutathione hydrolase |
chr3_-_95882031 | 4.28 |
ENSMUST00000161994.1
|
Gm129
|
predicted gene 129 |
chr5_-_31154152 | 4.26 |
ENSMUST00000114632.1
ENSMUST00000114631.2 ENSMUST00000067186.6 ENSMUST00000137165.1 ENSMUST00000131391.1 ENSMUST00000141823.1 ENSMUST00000154241.1 |
Mpv17
|
MpV17 mitochondrial inner membrane protein |
chr1_+_88211956 | 4.24 |
ENSMUST00000073049.6
|
Ugt1a1
|
UDP glucuronosyltransferase 1 family, polypeptide A1 |
chr15_-_10714612 | 4.23 |
ENSMUST00000169385.1
|
Rai14
|
retinoic acid induced 14 |
chr5_+_30921556 | 4.23 |
ENSMUST00000031053.8
|
Khk
|
ketohexokinase |
chr1_+_135818593 | 4.19 |
ENSMUST00000038760.8
|
Lad1
|
ladinin |
chr14_-_118052235 | 4.19 |
ENSMUST00000022725.2
|
Dct
|
dopachrome tautomerase |
chr11_-_70239794 | 4.19 |
ENSMUST00000040428.3
|
Rnasek
|
ribonuclease, RNase K |
chr7_-_90475971 | 4.17 |
ENSMUST00000032843.7
|
Tmem126b
|
transmembrane protein 126B |
chr16_-_23988852 | 4.17 |
ENSMUST00000023151.5
|
Bcl6
|
B cell leukemia/lymphoma 6 |
chr7_+_44384604 | 4.16 |
ENSMUST00000130707.1
ENSMUST00000130844.1 |
Syt3
|
synaptotagmin III |
chr7_+_44384803 | 4.09 |
ENSMUST00000120262.1
|
Syt3
|
synaptotagmin III |
chr2_-_164833438 | 4.09 |
ENSMUST00000042775.4
|
Neurl2
|
neuralized-like 2 (Drosophila) |
chr5_+_28165690 | 4.09 |
ENSMUST00000036177.7
|
En2
|
engrailed 2 |
chr10_+_77606571 | 4.04 |
ENSMUST00000099538.5
|
Sumo3
|
SMT3 suppressor of mif two 3 homolog 3 (yeast) |
chr15_-_76126538 | 4.03 |
ENSMUST00000054022.5
ENSMUST00000089654.3 |
BC024139
|
cDNA sequence BC024139 |
chr2_+_28641227 | 4.00 |
ENSMUST00000028155.5
ENSMUST00000113869.1 ENSMUST00000113867.2 |
Tsc1
|
tuberous sclerosis 1 |
chr1_-_183297008 | 3.96 |
ENSMUST00000057062.5
|
Brox
|
BRO1 domain and CAAX motif containing |
chr6_+_108660616 | 3.93 |
ENSMUST00000032194.4
|
Bhlhe40
|
basic helix-loop-helix family, member e40 |
chr11_-_52000432 | 3.92 |
ENSMUST00000020657.6
|
Ube2b
|
ubiquitin-conjugating enzyme E2B |
chr18_+_31759817 | 3.90 |
ENSMUST00000115808.2
|
Ammecr1l
|
AMME chromosomal region gene 1-like |
chr2_+_90847149 | 3.87 |
ENSMUST00000136872.1
|
Mtch2
|
mitochondrial carrier homolog 2 (C. elegans) |
chr2_+_127425155 | 3.87 |
ENSMUST00000062211.3
ENSMUST00000110373.1 |
Gpat2
|
glycerol-3-phosphate acyltransferase 2, mitochondrial |
chr16_-_5049882 | 3.85 |
ENSMUST00000023189.7
ENSMUST00000115844.1 |
Glyr1
|
glyoxylate reductase 1 homolog (Arabidopsis) |
chr3_+_89202916 | 3.80 |
ENSMUST00000077367.4
ENSMUST00000167998.1 |
Gba
|
glucosidase, beta, acid |
chr17_+_25133385 | 3.79 |
ENSMUST00000040729.2
|
Clcn7
|
chloride channel 7 |
chr11_+_73199445 | 3.76 |
ENSMUST00000006105.6
|
Shpk
|
sedoheptulokinase |
chr11_-_5915124 | 3.73 |
ENSMUST00000109823.2
ENSMUST00000109822.1 |
Gck
|
glucokinase |
chr1_+_171345684 | 3.72 |
ENSMUST00000006579.4
|
Pfdn2
|
prefoldin 2 |
chr2_+_90847207 | 3.69 |
ENSMUST00000150232.1
ENSMUST00000111467.3 |
Mtch2
|
mitochondrial carrier homolog 2 (C. elegans) |
chr11_+_120673359 | 3.68 |
ENSMUST00000135346.1
ENSMUST00000127269.1 ENSMUST00000131727.2 ENSMUST00000149389.1 ENSMUST00000153346.1 |
Aspscr1
|
alveolar soft part sarcoma chromosome region, candidate 1 (human) |
chr5_+_107331157 | 3.68 |
ENSMUST00000031215.8
ENSMUST00000112677.3 |
Brdt
|
bromodomain, testis-specific |
chr16_-_45158566 | 3.66 |
ENSMUST00000181177.1
|
Slc35a5
|
solute carrier family 35, member A5 |
chr6_-_108185552 | 3.62 |
ENSMUST00000167338.1
ENSMUST00000172188.1 ENSMUST00000032191.9 |
Sumf1
|
sulfatase modifying factor 1 |
chr5_+_30921867 | 3.61 |
ENSMUST00000123885.1
|
Khk
|
ketohexokinase |
chr9_+_77917364 | 3.60 |
ENSMUST00000034904.7
|
Elovl5
|
ELOVL family member 5, elongation of long chain fatty acids (yeast) |
chr1_-_139560158 | 3.59 |
ENSMUST00000160423.1
ENSMUST00000023965.5 |
Cfhr1
|
complement factor H-related 1 |
chr14_+_34819811 | 3.56 |
ENSMUST00000043349.5
|
Grid1
|
glutamate receptor, ionotropic, delta 1 |
chr18_-_6135888 | 3.54 |
ENSMUST00000182383.1
ENSMUST00000062584.7 ENSMUST00000077128.6 ENSMUST00000182038.1 ENSMUST00000182213.1 |
Arhgap12
|
Rho GTPase activating protein 12 |
chr11_-_96075581 | 3.51 |
ENSMUST00000107686.1
ENSMUST00000107684.1 |
Atp5g1
|
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit c1 (subunit 9) |
chr17_+_46383725 | 3.50 |
ENSMUST00000113481.1
ENSMUST00000138127.1 |
Zfp318
|
zinc finger protein 318 |
chr16_-_44139196 | 3.45 |
ENSMUST00000063661.6
ENSMUST00000114666.2 |
Atp6v1a
|
ATPase, H+ transporting, lysosomal V1 subunit A |
chr5_-_139814231 | 3.43 |
ENSMUST00000044002.4
|
Tmem184a
|
transmembrane protein 184a |
chr7_+_119526269 | 3.42 |
ENSMUST00000066465.1
|
Acsm5
|
acyl-CoA synthetase medium-chain family member 5 |
chr11_-_72266596 | 3.42 |
ENSMUST00000021161.6
ENSMUST00000140167.1 |
Slc13a5
|
solute carrier family 13 (sodium-dependent citrate transporter), member 5 |
chr17_-_32917048 | 3.37 |
ENSMUST00000054174.7
|
Cyp4f14
|
cytochrome P450, family 4, subfamily f, polypeptide 14 |
chr7_+_121707189 | 3.36 |
ENSMUST00000065310.2
|
1700069B07Rik
|
RIKEN cDNA 1700069B07 gene |
chr4_-_119422355 | 3.35 |
ENSMUST00000106316.1
ENSMUST00000030385.6 |
Ppcs
|
phosphopantothenoylcysteine synthetase |
chr8_-_24576297 | 3.35 |
ENSMUST00000033953.7
ENSMUST00000121992.1 |
Ido2
|
indoleamine 2,3-dioxygenase 2 |
chr10_+_128322443 | 3.35 |
ENSMUST00000026446.2
|
Cnpy2
|
canopy 2 homolog (zebrafish) |
chr11_-_88863717 | 3.33 |
ENSMUST00000107904.2
|
Akap1
|
A kinase (PRKA) anchor protein 1 |
chr17_-_26508463 | 3.33 |
ENSMUST00000025025.6
|
Dusp1
|
dual specificity phosphatase 1 |
chr7_-_35802968 | 3.31 |
ENSMUST00000061586.4
|
Zfp507
|
zinc finger protein 507 |
chr7_-_126583523 | 3.31 |
ENSMUST00000125508.1
ENSMUST00000147086.1 ENSMUST00000150587.1 |
Cln3
|
ceroid lipofuscinosis, neuronal 3, juvenile (Batten, Spielmeyer-Vogt disease) |
chr11_+_60777525 | 3.30 |
ENSMUST00000056907.6
ENSMUST00000102667.3 |
Smcr8
|
Smith-Magenis syndrome chromosome region, candidate 8 homolog (human) |
chr10_-_41587753 | 3.28 |
ENSMUST00000160751.1
|
Ccdc162
|
coiled-coil domain containing 162 |
chr9_-_48605147 | 3.27 |
ENSMUST00000034808.5
ENSMUST00000119426.1 |
Nnmt
|
nicotinamide N-methyltransferase |
chr11_+_94653767 | 3.24 |
ENSMUST00000025278.7
|
Mrpl27
|
mitochondrial ribosomal protein L27 |
chr11_-_60811228 | 3.20 |
ENSMUST00000018744.8
|
Shmt1
|
serine hydroxymethyltransferase 1 (soluble) |
chr11_-_86993682 | 3.20 |
ENSMUST00000018571.4
|
Ypel2
|
yippee-like 2 (Drosophila) |
chr10_-_81060134 | 3.19 |
ENSMUST00000005067.5
|
Sgta
|
small glutamine-rich tetratricopeptide repeat (TPR)-containing, alpha |
chr4_-_96664112 | 3.17 |
ENSMUST00000030299.7
|
Cyp2j5
|
cytochrome P450, family 2, subfamily j, polypeptide 5 |
chr3_-_129332713 | 3.16 |
ENSMUST00000029658.7
|
Enpep
|
glutamyl aminopeptidase |
chr1_+_171225054 | 3.16 |
ENSMUST00000111321.1
ENSMUST00000005824.5 ENSMUST00000111320.1 ENSMUST00000111319.1 |
Apoa2
|
apolipoprotein A-II |
chr8_+_75033673 | 3.13 |
ENSMUST00000078847.5
ENSMUST00000165630.1 |
Tom1
|
target of myb1 homolog (chicken) |
chr1_-_162984519 | 3.13 |
ENSMUST00000028010.7
|
Fmo3
|
flavin containing monooxygenase 3 |
chr7_-_27166413 | 3.12 |
ENSMUST00000108382.1
|
Egln2
|
EGL nine homolog 2 (C. elegans) |
chr5_+_138171997 | 3.11 |
ENSMUST00000019662.4
ENSMUST00000151318.1 |
Ap4m1
|
adaptor-related protein complex AP-4, mu 1 |
chr17_+_33824591 | 3.09 |
ENSMUST00000048249.6
|
Ndufa7
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 7 (B14.5a) |
chr6_-_39377681 | 3.07 |
ENSMUST00000090243.4
|
Slc37a3
|
solute carrier family 37 (glycerol-3-phosphate transporter), member 3 |
chr1_-_136960427 | 3.05 |
ENSMUST00000027649.7
|
Nr5a2
|
nuclear receptor subfamily 5, group A, member 2 |
chr11_-_96075655 | 3.04 |
ENSMUST00000090541.5
|
Atp5g1
|
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit c1 (subunit 9) |
chr6_+_116208030 | 3.01 |
ENSMUST00000036759.8
|
Fam21
|
family with sequence similarity 21 |
chr6_+_17694167 | 3.01 |
ENSMUST00000115418.1
|
St7
|
suppression of tumorigenicity 7 |
chrX_-_100412587 | 2.98 |
ENSMUST00000033567.8
|
Awat2
|
acyl-CoA wax alcohol acyltransferase 2 |
chr4_-_70534904 | 2.98 |
ENSMUST00000107359.2
|
Megf9
|
multiple EGF-like-domains 9 |
chr19_+_39007019 | 2.97 |
ENSMUST00000025966.4
|
Cyp2c55
|
cytochrome P450, family 2, subfamily c, polypeptide 55 |
chr11_+_53350783 | 2.96 |
ENSMUST00000060945.5
|
Aff4
|
AF4/FMR2 family, member 4 |
chr16_-_45158624 | 2.92 |
ENSMUST00000180636.1
|
Slc35a5
|
solute carrier family 35, member A5 |
chr18_-_80151467 | 2.92 |
ENSMUST00000066743.9
|
Adnp2
|
ADNP homeobox 2 |
chr8_-_13890233 | 2.91 |
ENSMUST00000033839.7
|
Coprs
|
coordinator of PRMT5, differentiation stimulator |
chr19_-_58860975 | 2.91 |
ENSMUST00000066285.4
|
Hspa12a
|
heat shock protein 12A |
chr19_-_44407703 | 2.90 |
ENSMUST00000041331.2
|
Scd1
|
stearoyl-Coenzyme A desaturase 1 |
chr10_+_23894688 | 2.89 |
ENSMUST00000041416.7
|
Vnn1
|
vanin 1 |
chr5_+_138255608 | 2.87 |
ENSMUST00000062067.6
|
Lamtor4
|
late endosomal/lysosomal adaptor, MAPK and MTOR activator 4 |
chr19_-_39463067 | 2.87 |
ENSMUST00000035488.2
|
Cyp2c38
|
cytochrome P450, family 2, subfamily c, polypeptide 38 |
chr5_-_120503593 | 2.86 |
ENSMUST00000031597.6
|
Plbd2
|
phospholipase B domain containing 2 |
chr17_-_56074932 | 2.85 |
ENSMUST00000019722.5
|
Ubxn6
|
UBX domain protein 6 |
chr9_+_102626278 | 2.85 |
ENSMUST00000038673.7
|
Anapc13
|
anaphase promoting complex subunit 13 |
chr4_-_122961173 | 2.83 |
ENSMUST00000030408.5
ENSMUST00000127047.1 |
Mfsd2a
|
major facilitator superfamily domain containing 2A |
chr10_-_78464969 | 2.81 |
ENSMUST00000041616.8
|
Pdxk
|
pyridoxal (pyridoxine, vitamin B6) kinase |
chr12_-_103904887 | 2.81 |
ENSMUST00000074051.5
|
Serpina1c
|
serine (or cysteine) peptidase inhibitor, clade A, member 1C |
chr5_-_86518578 | 2.76 |
ENSMUST00000134179.1
|
Tmprss11g
|
transmembrane protease, serine 11g |
chr12_+_86947343 | 2.75 |
ENSMUST00000038369.4
|
2310044G17Rik
|
RIKEN cDNA 2310044G17 gene |
chrX_-_85776606 | 2.74 |
ENSMUST00000142152.1
ENSMUST00000156390.1 ENSMUST00000113978.2 |
Gyk
|
glycerol kinase |
chr4_-_96553617 | 2.72 |
ENSMUST00000030303.5
|
Cyp2j6
|
cytochrome P450, family 2, subfamily j, polypeptide 6 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.1 | 40.4 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
8.5 | 25.5 | GO:0043323 | positive regulation of natural killer cell degranulation(GO:0043323) |
3.8 | 15.3 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
3.8 | 15.2 | GO:0071718 | sodium-independent icosanoid transport(GO:0071718) |
3.8 | 11.4 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
3.6 | 14.4 | GO:0061624 | fructose catabolic process(GO:0006001) response to sucrose(GO:0009744) response to disaccharide(GO:0034285) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
3.5 | 20.9 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
2.5 | 15.3 | GO:0010288 | response to lead ion(GO:0010288) |
2.5 | 7.4 | GO:0019405 | alditol catabolic process(GO:0019405) |
2.5 | 7.4 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
2.1 | 6.4 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
2.0 | 12.0 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
1.9 | 11.7 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
1.9 | 9.3 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
1.7 | 5.2 | GO:1902617 | response to fluoride(GO:1902617) |
1.7 | 5.1 | GO:0010845 | positive regulation of reciprocal meiotic recombination(GO:0010845) |
1.7 | 5.1 | GO:1902568 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
1.7 | 5.0 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
1.6 | 8.2 | GO:0043379 | memory T cell differentiation(GO:0043379) |
1.6 | 4.7 | GO:0006583 | melanin biosynthetic process from tyrosine(GO:0006583) |
1.5 | 6.1 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
1.5 | 6.0 | GO:0015744 | succinate transport(GO:0015744) |
1.4 | 13.9 | GO:0061727 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
1.4 | 4.1 | GO:0060785 | regulation of apoptosis involved in tissue homeostasis(GO:0060785) |
1.4 | 4.1 | GO:0060752 | negative regulation of intestinal phytosterol absorption(GO:0010949) negative regulation of intestinal cholesterol absorption(GO:0045796) intestinal phytosterol absorption(GO:0060752) negative regulation of intestinal lipid absorption(GO:1904730) |
1.3 | 8.1 | GO:0018992 | germ-line sex determination(GO:0018992) |
1.3 | 4.0 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
1.3 | 9.0 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
1.3 | 5.1 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
1.3 | 3.8 | GO:0043181 | vacuolar sequestering(GO:0043181) |
1.2 | 4.8 | GO:0090126 | protein complex assembly involved in synapse maturation(GO:0090126) |
1.2 | 8.5 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
1.1 | 3.4 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
1.1 | 4.5 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
1.1 | 4.5 | GO:0034031 | coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) acetyl-CoA catabolic process(GO:0046356) |
1.1 | 4.4 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
1.1 | 3.3 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
1.1 | 3.2 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
1.0 | 3.1 | GO:1903381 | neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
1.0 | 33.6 | GO:0015991 | ATP hydrolysis coupled proton transport(GO:0015991) |
1.0 | 4.0 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
1.0 | 12.9 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
1.0 | 3.0 | GO:0070342 | brown fat cell proliferation(GO:0070342) regulation of brown fat cell proliferation(GO:0070347) |
0.9 | 2.8 | GO:0051977 | lysophospholipid transport(GO:0051977) |
0.9 | 3.8 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.9 | 1.9 | GO:0045914 | negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
0.9 | 2.7 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.9 | 2.7 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
0.9 | 2.7 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.9 | 6.3 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.9 | 2.7 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.9 | 12.5 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.9 | 2.6 | GO:0070625 | zymogen granule exocytosis(GO:0070625) |
0.9 | 4.3 | GO:0070859 | positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
0.9 | 2.6 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) |
0.8 | 3.4 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.8 | 2.5 | GO:0061402 | positive regulation of transcription from RNA polymerase II promoter in response to acidic pH(GO:0061402) |
0.8 | 3.4 | GO:0034769 | basement membrane disassembly(GO:0034769) |
0.8 | 19.3 | GO:0099514 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.8 | 4.2 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
0.8 | 3.3 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
0.8 | 2.4 | GO:0042823 | pyridoxal phosphate biosynthetic process(GO:0042823) |
0.8 | 2.4 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.8 | 3.1 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.7 | 2.2 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.7 | 5.9 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.7 | 3.7 | GO:0051594 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.7 | 11.8 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.7 | 2.9 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.7 | 1.4 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.7 | 8.6 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.7 | 2.8 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.7 | 3.5 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
0.7 | 4.2 | GO:0015889 | cobalamin transport(GO:0015889) |
0.7 | 5.6 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.7 | 2.1 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.7 | 2.7 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.7 | 2.7 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.7 | 3.3 | GO:0070494 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
0.7 | 4.6 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.6 | 0.6 | GO:1904173 | regulation of histone demethylase activity (H3-K4 specific)(GO:1904173) |
0.6 | 3.2 | GO:0032902 | nerve growth factor production(GO:0032902) |
0.6 | 2.5 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.6 | 1.9 | GO:1990166 | protein localization to site of double-strand break(GO:1990166) |
0.6 | 1.9 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.6 | 20.5 | GO:0010866 | regulation of triglyceride biosynthetic process(GO:0010866) |
0.6 | 2.5 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.6 | 5.5 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.6 | 1.8 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.6 | 8.3 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.6 | 7.6 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.6 | 2.3 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.6 | 4.5 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
0.6 | 12.9 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.6 | 0.6 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.6 | 7.2 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.5 | 2.2 | GO:0097494 | regulation of vesicle size(GO:0097494) |
0.5 | 1.6 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.5 | 1.6 | GO:0060168 | positive regulation of adenosine receptor signaling pathway(GO:0060168) regulation of G-protein coupled receptor internalization(GO:1904020) |
0.5 | 2.7 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.5 | 7.5 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.5 | 2.1 | GO:0071449 | response to lipid hydroperoxide(GO:0006982) cellular response to lipid hydroperoxide(GO:0071449) |
0.5 | 12.9 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.5 | 4.1 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.5 | 6.1 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.5 | 1.5 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.5 | 3.0 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.5 | 4.9 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.5 | 1.5 | GO:0019343 | cysteine biosynthetic process via cystathionine(GO:0019343) |
0.5 | 1.5 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.5 | 5.8 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.5 | 1.4 | GO:0070904 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
0.5 | 1.9 | GO:1903760 | regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903760) |
0.5 | 2.4 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.5 | 3.3 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.5 | 0.9 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.5 | 3.3 | GO:0002003 | angiotensin maturation(GO:0002003) |
0.5 | 5.1 | GO:0035878 | nail development(GO:0035878) |
0.5 | 2.7 | GO:0070459 | prolactin secretion(GO:0070459) |
0.4 | 0.9 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.4 | 0.9 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.4 | 1.8 | GO:0061055 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) myotome development(GO:0061055) |
0.4 | 4.0 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.4 | 0.9 | GO:0070948 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.4 | 10.1 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.4 | 0.9 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.4 | 1.7 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.4 | 3.0 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.4 | 3.0 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.4 | 2.2 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
0.4 | 4.3 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.4 | 4.2 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.4 | 7.6 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
0.4 | 1.3 | GO:0032242 | regulation of nucleoside transport(GO:0032242) negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
0.4 | 1.2 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.4 | 2.5 | GO:0015808 | L-alanine transport(GO:0015808) |
0.4 | 6.2 | GO:0042407 | cristae formation(GO:0042407) |
0.4 | 4.1 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.4 | 1.6 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
0.4 | 7.2 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.4 | 4.4 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.4 | 1.2 | GO:0001982 | baroreceptor response to decreased systemic arterial blood pressure(GO:0001982) |
0.4 | 2.4 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
0.4 | 2.0 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.4 | 0.4 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
0.4 | 1.9 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.4 | 2.3 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.4 | 0.8 | GO:1903542 | negative regulation of exosomal secretion(GO:1903542) |
0.4 | 1.1 | GO:0000101 | sulfur amino acid transport(GO:0000101) negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) L-cystine transport(GO:0015811) |
0.4 | 1.1 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
0.4 | 1.1 | GO:0002014 | vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
0.4 | 9.0 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.4 | 1.1 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.4 | 0.4 | GO:0090034 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
0.4 | 0.7 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.4 | 1.9 | GO:0006548 | histidine catabolic process(GO:0006548) |
0.4 | 1.1 | GO:0021893 | cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
0.4 | 0.7 | GO:0061026 | septum secundum development(GO:0003285) cardiac muscle tissue regeneration(GO:0061026) |
0.4 | 0.7 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.4 | 0.7 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.4 | 1.1 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
0.4 | 7.4 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.4 | 1.4 | GO:0032782 | bile acid secretion(GO:0032782) |
0.3 | 3.8 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.3 | 2.8 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.3 | 2.1 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.3 | 0.3 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.3 | 1.7 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.3 | 1.0 | GO:2000851 | positive regulation of glucocorticoid secretion(GO:2000851) |
0.3 | 3.7 | GO:0046218 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) kynurenine metabolic process(GO:0070189) |
0.3 | 0.3 | GO:0002465 | peripheral T cell tolerance induction(GO:0002458) peripheral tolerance induction(GO:0002465) |
0.3 | 2.7 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.3 | 1.3 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.3 | 0.7 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.3 | 1.0 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.3 | 1.3 | GO:1903215 | regulation of mRNA modification(GO:0090365) negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.3 | 1.0 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.3 | 3.0 | GO:0060179 | male mating behavior(GO:0060179) |
0.3 | 5.5 | GO:0000338 | protein deneddylation(GO:0000338) |
0.3 | 1.3 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
0.3 | 1.0 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) |
0.3 | 2.2 | GO:0030299 | intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
0.3 | 1.3 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
0.3 | 2.2 | GO:0030242 | pexophagy(GO:0030242) |
0.3 | 4.7 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.3 | 3.8 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.3 | 2.2 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.3 | 1.6 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.3 | 0.9 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.3 | 0.6 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.3 | 1.2 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.3 | 0.9 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.3 | 0.9 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.3 | 0.9 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) positive regulation of growth rate(GO:0040010) |
0.3 | 0.3 | GO:0061347 | planar cell polarity pathway involved in outflow tract morphogenesis(GO:0061347) planar cell polarity pathway involved in ventricular septum morphogenesis(GO:0061348) planar cell polarity pathway involved in cardiac right atrium morphogenesis(GO:0061349) planar cell polarity pathway involved in cardiac muscle tissue morphogenesis(GO:0061350) planar cell polarity pathway involved in pericardium morphogenesis(GO:0061354) |
0.3 | 0.6 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.3 | 1.2 | GO:0019471 | 4-hydroxyproline metabolic process(GO:0019471) |
0.3 | 0.9 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.3 | 0.9 | GO:0002884 | negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) negative regulation of hypersensitivity(GO:0002884) |
0.3 | 0.3 | GO:0016240 | autophagosome docking(GO:0016240) |
0.3 | 5.1 | GO:1902176 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902176) |
0.3 | 1.7 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.3 | 1.1 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.3 | 1.4 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.3 | 11.7 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.3 | 1.9 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.3 | 1.1 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.3 | 1.1 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
0.3 | 4.1 | GO:1990403 | embryonic brain development(GO:1990403) |
0.3 | 0.5 | GO:0006547 | histidine metabolic process(GO:0006547) |
0.3 | 0.8 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.3 | 0.8 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
0.3 | 0.8 | GO:1903048 | regulation of acetylcholine-gated cation channel activity(GO:1903048) |
0.3 | 1.1 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.3 | 1.1 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.3 | 12.2 | GO:0006953 | acute-phase response(GO:0006953) |
0.3 | 5.1 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.3 | 1.6 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.3 | 0.8 | GO:0015865 | purine nucleotide transport(GO:0015865) purine ribonucleotide transport(GO:0015868) |
0.3 | 3.9 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.3 | 1.1 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.3 | 1.3 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.3 | 0.8 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.3 | 0.8 | GO:0006710 | androgen catabolic process(GO:0006710) |
0.3 | 1.8 | GO:1901072 | glucosamine-containing compound catabolic process(GO:1901072) |
0.3 | 0.5 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.3 | 1.0 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.2 | 1.5 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.2 | 0.5 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
0.2 | 5.4 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.2 | 0.7 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen(GO:0002478) antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.2 | 0.7 | GO:0003167 | atrioventricular bundle cell differentiation(GO:0003167) His-Purkinje system cell differentiation(GO:0060932) |
0.2 | 1.2 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.2 | 0.5 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.2 | 1.0 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.2 | 0.7 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
0.2 | 1.0 | GO:1902045 | regulation of Fas signaling pathway(GO:1902044) negative regulation of Fas signaling pathway(GO:1902045) |
0.2 | 4.3 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.2 | 0.7 | GO:0002343 | peripheral B cell selection(GO:0002343) B cell affinity maturation(GO:0002344) |
0.2 | 1.7 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.2 | 1.2 | GO:0015888 | thiamine transport(GO:0015888) |
0.2 | 0.7 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.2 | 9.7 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.2 | 1.4 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.2 | 0.9 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.2 | 1.1 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.2 | 0.7 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
0.2 | 0.7 | GO:0015755 | fructose transport(GO:0015755) |
0.2 | 1.6 | GO:0014850 | response to muscle activity(GO:0014850) |
0.2 | 1.1 | GO:0033762 | response to glucagon(GO:0033762) |
0.2 | 0.9 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.2 | 2.9 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.2 | 11.0 | GO:0006956 | complement activation(GO:0006956) |
0.2 | 0.7 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.2 | 2.7 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
0.2 | 0.7 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.2 | 0.4 | GO:1903817 | negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.2 | 1.5 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
0.2 | 0.7 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
0.2 | 3.5 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.2 | 0.9 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.2 | 0.4 | GO:0046439 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.2 | 2.4 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.2 | 0.9 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.2 | 0.6 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.2 | 1.3 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.2 | 1.0 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.2 | 0.8 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.2 | 1.0 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.2 | 1.0 | GO:0021764 | amygdala development(GO:0021764) |
0.2 | 1.8 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.2 | 2.4 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.2 | 4.7 | GO:0017144 | drug metabolic process(GO:0017144) |
0.2 | 3.4 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.2 | 5.8 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.2 | 1.6 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.2 | 0.4 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
0.2 | 0.8 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.2 | 0.4 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.2 | 0.8 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.2 | 1.2 | GO:0019532 | oxalate transport(GO:0019532) |
0.2 | 0.4 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.2 | 1.8 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.2 | 11.3 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.2 | 1.9 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.2 | 0.6 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.2 | 0.6 | GO:2000170 | positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
0.2 | 0.2 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.2 | 0.4 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.2 | 1.7 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.2 | 3.5 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.2 | 0.6 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
0.2 | 1.3 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.2 | 4.0 | GO:0007141 | male meiosis I(GO:0007141) |
0.2 | 1.5 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.2 | 0.9 | GO:1904720 | regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
0.2 | 33.3 | GO:0008643 | carbohydrate transport(GO:0008643) |
0.2 | 1.3 | GO:0046479 | glycosphingolipid catabolic process(GO:0046479) |
0.2 | 0.7 | GO:0016259 | selenium compound metabolic process(GO:0001887) selenocysteine metabolic process(GO:0016259) |
0.2 | 2.3 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.2 | 0.5 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.2 | 1.1 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.2 | 0.5 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.2 | 3.3 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.2 | 1.9 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.2 | 0.5 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.2 | 0.9 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.2 | 1.2 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.2 | 0.7 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.2 | 0.5 | GO:0006203 | dGTP catabolic process(GO:0006203) dATP catabolic process(GO:0046061) |
0.2 | 1.5 | GO:0071569 | protein ufmylation(GO:0071569) |
0.2 | 1.0 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.2 | 1.3 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
0.2 | 1.2 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.2 | 3.7 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.2 | 2.0 | GO:0034312 | diol biosynthetic process(GO:0034312) |
0.2 | 1.0 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.2 | 3.0 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.2 | 6.8 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.2 | 0.6 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.2 | 1.6 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.2 | 0.5 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
0.2 | 0.6 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.2 | 0.2 | GO:0007521 | muscle cell fate determination(GO:0007521) |
0.2 | 0.6 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.2 | 1.9 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.2 | 0.3 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.2 | 0.3 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.2 | 0.9 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.2 | 1.9 | GO:0090148 | membrane fission(GO:0090148) |
0.2 | 0.9 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.2 | 0.2 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.2 | 0.8 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.2 | 2.6 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.2 | 0.3 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.2 | 0.8 | GO:0072181 | mesonephric duct formation(GO:0072181) |
0.2 | 0.6 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.2 | 1.7 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.1 | 1.5 | GO:0016559 | peroxisome fission(GO:0016559) |
0.1 | 0.6 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.1 | 1.6 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 0.6 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.1 | 0.4 | GO:0072425 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
0.1 | 0.3 | GO:0071707 | immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
0.1 | 5.8 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.1 | 1.3 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.1 | 0.6 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.1 | 0.3 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.1 | 1.7 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.1 | 2.0 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.1 | 0.6 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.1 | 2.4 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.1 | 0.4 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
0.1 | 0.8 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.1 | 0.7 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.1 | 0.3 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.1 | 2.0 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 1.1 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.1 | 1.1 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.1 | 0.7 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 0.4 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.1 | 1.7 | GO:0015695 | organic cation transport(GO:0015695) |
0.1 | 2.4 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.1 | 0.9 | GO:0070627 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) ferrous iron import(GO:0070627) ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
0.1 | 0.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 1.3 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.1 | 1.5 | GO:0030262 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.1 | 0.7 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.1 | 0.8 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.1 | 0.4 | GO:0072343 | pancreatic stellate cell proliferation(GO:0072343) regulation of pancreatic stellate cell proliferation(GO:2000229) |
0.1 | 0.5 | GO:0060857 | establishment of glial blood-brain barrier(GO:0060857) |
0.1 | 1.6 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.1 | 4.0 | GO:0001706 | endoderm formation(GO:0001706) |
0.1 | 1.2 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.5 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.1 | 0.8 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.1 | 0.8 | GO:0051000 | positive regulation of nitric-oxide synthase activity(GO:0051000) |
0.1 | 1.6 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 1.2 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) vesicle uncoating(GO:0072319) |
0.1 | 11.2 | GO:0008203 | cholesterol metabolic process(GO:0008203) |
0.1 | 0.7 | GO:0097264 | self proteolysis(GO:0097264) |
0.1 | 4.8 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.1 | 0.4 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.1 | 0.4 | GO:1901950 | dense core granule localization(GO:0032253) dense core granule transport(GO:1901950) regulation of dense core granule transport(GO:1904809) positive regulation of dense core granule transport(GO:1904811) |
0.1 | 2.0 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.8 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.1 | 0.5 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.1 | 1.4 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.1 | 0.3 | GO:0000448 | cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000448) |
0.1 | 3.5 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 1.5 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 3.0 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.1 | 1.0 | GO:0033574 | response to testosterone(GO:0033574) |
0.1 | 1.0 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.1 | 0.2 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
0.1 | 0.9 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 0.3 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.1 | 0.2 | GO:0009204 | deoxyribonucleoside triphosphate catabolic process(GO:0009204) |
0.1 | 1.0 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.1 | 1.5 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.5 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 0.6 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 0.6 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.1 | 0.4 | GO:1904995 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.1 | 1.5 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.4 | GO:0070071 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting two-sector ATPase complex assembly(GO:0070071) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.1 | 0.7 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 | 5.9 | GO:0035383 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.1 | 4.0 | GO:0007032 | endosome organization(GO:0007032) |
0.1 | 0.6 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.1 | 0.7 | GO:0060768 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.1 | 0.6 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 1.2 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.1 | 1.2 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.1 | 0.6 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.1 | 0.3 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.1 | 0.3 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.1 | 0.6 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
0.1 | 0.3 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 1.6 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.1 | 2.4 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.1 | 0.9 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 1.5 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 0.3 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
0.1 | 0.9 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.1 | 4.4 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.1 | 1.3 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.1 | 1.2 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.1 | 2.0 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 0.7 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.1 | 0.6 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.1 | 3.6 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.1 | 1.3 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.1 | 0.3 | GO:0051280 | negative regulation of release of sequestered calcium ion into cytosol(GO:0051280) positive regulation of sequestering of calcium ion(GO:0051284) |
0.1 | 0.3 | GO:0007210 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) serotonin receptor signaling pathway(GO:0007210) |
0.1 | 5.8 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.1 | 1.0 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 1.2 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.3 | GO:0052203 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.1 | 0.5 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.1 | 2.1 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 | 0.4 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.1 | 0.4 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.1 | 1.8 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.1 | 0.3 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.1 | 0.3 | GO:0000239 | pachytene(GO:0000239) |
0.1 | 0.5 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
0.1 | 0.3 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
0.1 | 2.0 | GO:1901264 | carbohydrate derivative transport(GO:1901264) |
0.1 | 2.1 | GO:0006739 | NADP metabolic process(GO:0006739) |
0.1 | 3.0 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.3 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.1 | 0.2 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
0.1 | 0.9 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.1 | 0.3 | GO:2000858 | mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
0.1 | 0.6 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.2 | GO:0099542 | trans-synaptic signaling by lipid(GO:0099541) trans-synaptic signaling by endocannabinoid(GO:0099542) trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
0.1 | 0.3 | GO:0052042 | induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) |
0.1 | 0.7 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 1.6 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.1 | 0.3 | GO:0030576 | Cajal body organization(GO:0030576) |
0.1 | 0.7 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.1 | 0.8 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 2.3 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.1 | 3.4 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.1 | 0.3 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.1 | 0.3 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
0.1 | 1.1 | GO:0046697 | decidualization(GO:0046697) |
0.1 | 0.9 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 1.7 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.1 | 1.2 | GO:0044804 | nucleophagy(GO:0044804) |
0.1 | 0.9 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 1.1 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 1.6 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.1 | 2.8 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.1 | 0.5 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.4 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 0.2 | GO:0015881 | creatine transport(GO:0015881) |
0.1 | 0.8 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.1 | 1.7 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.1 | 0.2 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.1 | 0.6 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.7 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.1 | 0.7 | GO:0060180 | female mating behavior(GO:0060180) |
0.1 | 0.2 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.1 | 0.9 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.1 | 0.3 | GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development(GO:0072272) |
0.1 | 0.5 | GO:1902548 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.1 | 0.4 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 0.6 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 0.4 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.1 | 0.1 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.1 | 0.4 | GO:0097151 |